GALDERMA GROUP AG reports a Return on Equity (ROE) of 7.52%.

What is GALDY's dividend yield?

GALDERMA GROUP AG offers a dividend yield of 0.20%.

What is GALDY's Quality Score?

Our AI rates GALDY's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy GALDY?

Our AI Timing Score for GALDY is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does GALDY belong to?

GALDERMA GROUP AG is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange

GALDY (NYSE) Stock Analysis | GALDERMA GROUP AG

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2025-12-31)

GALDY AI Analysis Summary

Our AI summary for GALDY: GALDERMA GROUP AG (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of 7.52%, a dividend yield of 0.20%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

GALDY

GALDERMA GROUP AG

USD 43.60

-1.50 (-3.33%) Day Change

Watchlist Portfolio Compare Chart

0.32

D/E

7.5%

ROE

4.6%

ROA

0.20%

Div Yield

Data partially updated

GALDERMA GROUP AG
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 43.60 Price -1.50 (-3.33%) Day Change	NEWS SCORE: 99

GALDY, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Quality Factors

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	43.60
PBV / Sector	1.26 / 3.22 GOOD
Earning Per Share	2.61

PE / Sector	N/A / 29.79
PEG or PE/Growth / Sector	N/A / 0.13
Average 1M Daily Value	0.49 M GREAT
Average 1W Daily Value	0.35 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

52%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	11.70 / 15.21
NPM Average (%) / Sector	5.17 / -10.83
NPM Change Average (%) / Sector	-175.49 / 117.42
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	4.58 / 8.15
ROA Average (%) / Sector	1.98 / 2.87
ROA Change Average (%) / Sector	-175.29 / 112.70
ROE (%) / Sector	7.52 / -1.02
ROE Average (%) / Sector	3.14 / 8.35
ROE Change Average (%) / Sector	-112.82 / 385.91
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

12%

Dividend (%) / Sector	0.20 / 0.51
Dividend Average (%) / Sector	0.20 / 3.06
Dividend Change Average (%) / Sector	N/A / 13.64

Registration Details

Analyze Date	2026-08-01 07:59:53
Symbol	GALDY
Name	GALDERMA GROUP AG
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NYSE
Listed Shares	1,165.94 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	10,227.20 / 10,754.62

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Zählerweg 10, Zug, Switzerland, 6300

Phone: 41 58 455 85 92

Website: https://www.galderma.com

Employees: 7,676

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.